<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04654494</url>
  </required_header>
  <id_info>
    <org_study_id>REGISTROSPERIMENTAZIONI120/20</org_study_id>
    <nct_id>NCT04654494</nct_id>
  </id_info>
  <brief_title>Colorectal Cancer in Crohn's Disease</brief_title>
  <official_title>Colorectal Cancer in Crohn's Disease: Long Term Outcomes of Different Surgical Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rome Tor Vergata</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rome Tor Vergata</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective multicentre study. All patients with a diagnosis of Crohn's disease (CD) and&#xD;
      operated for colorectal cancer (CRC) between 01/01/2010 and 01/01/2020 will be included in&#xD;
      the dataset.&#xD;
&#xD;
      Data will include preoperative, intraoperative and postoperative variables, with long term&#xD;
      follow up when feasible.&#xD;
&#xD;
      The study will focus on a comparison between patients treated with total proctocolectomy&#xD;
      (TPC) and patients treated with subtotal colectomy (STC) or segmental resection (SR).&#xD;
&#xD;
      Primary endpoints will be oncologic outcomes, postoperative morbidity and mortality.&#xD;
      Secondary endpoints include quality of life (QoL).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>5 years</time_frame>
    <description>percentage of patients alive</description>
  </primary_outcome>
  <primary_outcome>
    <measure>disease free survival</measure>
    <time_frame>5 years</time_frame>
    <description>percentage of patients disease free</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Crohn Disease</condition>
  <condition>Colorectal Cancer</condition>
  <condition>Inflammatory Bowel Diseases</condition>
  <arm_group>
    <arm_group_label>Chron's disease patients with colorectal cancer</arm_group_label>
    <description>This group of patients with Chron's disease have been diagnosed with colorectal cancer and treated surgically</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total proctocolectomy</intervention_name>
    <description>excision of the whole large bowel including colon and rectum and end ileostomy fashioning</description>
    <arm_group_label>Chron's disease patients with colorectal cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total colectomy</intervention_name>
    <description>excision of the colon with preservation of the rectum</description>
    <arm_group_label>Chron's disease patients with colorectal cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Segmental colectomy</intervention_name>
    <description>excision of a segment of colon</description>
    <arm_group_label>Chron's disease patients with colorectal cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Crohn's disease complicated by occurrence of colorectal cancer, treated&#xD;
        surgically between 01/2010 and 01/2020&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients with a diagnosis of Crohn's disease and concomitant primary colorectal&#xD;
             cancer who underwent surgery in an expert centre between 01/01/2010 and 01/01/2020&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who underwent non-oncologic segmental resection will be excluded from outcome&#xD;
             analysis.&#xD;
&#xD;
          -  Patients with known genetic colorectal cancer syndromes (eg. Familial Adenomatous&#xD;
             Polyposis, Hereditary Non-Polyposis ColoRectal Cancer Syndrome)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bruno Sensi, MD</last_name>
    <phone>3385352902</phone>
    <email>brunosensi@outlook.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Giuseppe S Sica, MD, PhD</last_name>
    <phone>3385333659</phone>
    <email>sigisica@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Policlinico Tor Vergata</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Sensi, MD</last_name>
      <phone>3385352902</phone>
      <email>brunosensi@outlook.it</email>
    </contact>
    <contact_backup>
      <last_name>Giuseppe S Sica, MD, PhD</last_name>
      <phone>3385333659</phone>
      <email>sigisica@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 29, 2020</study_first_submitted>
  <study_first_submitted_qc>November 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2020</study_first_posted>
  <last_update_submitted>December 4, 2020</last_update_submitted>
  <last_update_submitted_qc>December 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rome Tor Vergata</investigator_affiliation>
    <investigator_full_name>Giuseppe Sigismondo Sica</investigator_full_name>
    <investigator_title>Associate Professor, Head of Department</investigator_title>
  </responsible_party>
  <keyword>colorectal surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

